Technical Analysis for CMPI - Checkmate Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 10.67 -6.81% -0.78
CMPI closed down 6.81 percent on Friday, September 18, 2020, on 5.67 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Down
Historical CMPI trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
New 52 Week Low Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Hot IPO Pullback Bullish Swing Setup -6.81%
Older End-of-Day Gignals for CMPI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 21 hours ago
Down 2 % about 23 hours ago
Outside Day about 23 hours ago
Down 1% about 23 hours ago
Fell Below Previous Day's Low about 23 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Checkmate Pharmaceuticals, Inc., a biotechnology company, develops novel immunotherapies for the treatment of cancer. It engages in the field of CpG oligonucleotides and validates an approach that combines the ability of CpG DNA to activate an anti-tumor T-cell response with checkpoint inhibition to overcome a tumor's ability to mute the immune response. The company has strategic alliances with Merck KGaA and Pfizer. Checkmate Pharmaceuticals, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
Medicine Biotechnology Health Cancer Pharmaceutical Industry Immunotherapy Treatment Of Cancer Immune System Virotherapy Cancer Immunotherapy Tumor Immunotherapies Pfizer Checkpoint Inhibitor

Is CMPI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.49
52 Week Low 10.48
Average Volume 102,329
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 13.32
10-Day Moving Average 11.44
Average True Range 1.25
ADX 30.5
+DI 10.69
-DI 23.72
Chandelier Exit (Long, 3 ATRs ) 12.73
Chandelier Exit (Short, 3 ATRs ) 14.24
Upper Bollinger Band 17.14
Lower Bollinger Band 9.49
Percent B (%b) 0.15
BandWidth 57.47
MACD Line -1.12
MACD Signal Line -0.85
MACD Histogram -0.2673
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.88
Resistance 3 (R3) 13.06 12.50 12.51
Resistance 2 (R2) 12.50 11.94 12.41 12.38
Resistance 1 (R1) 11.59 11.59 11.31 11.41 12.26
Pivot Point 11.03 11.03 10.90 10.94 11.03
Support 1 (S1) 10.12 10.47 9.84 9.94 9.08
Support 2 (S2) 9.56 10.12 9.47 8.96
Support 3 (S3) 8.65 9.56 8.83
Support 4 (S4) 8.47